Processa Pharmaceuticals’ $6.25 Million Common Stock Offering

Foley & Lardner represented Processa Pharmaceuticals, while Sichenzia Ross Ference represented Spartan Capital Securities in the offering.Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a diversified clinical-stage company developing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here